医学
脆性骨折
药物治疗
骨质疏松症
重症监护医学
物理疗法
内科学
骨矿物
作者
Kristine E. Ensrud,Carolyn Crandall
标识
DOI:10.7326/aitc201708010
摘要
This article has been corrected. The original version (PDF) is appended to this article as a Supplement. Osteoporosis is a common systemic skeletal disorder resulting in bone fragility and increased fracture risk. However, management of osteoporosis and fracture prevention strategies are often not addressed by primary care clinicians, even in older patients with recent fractures. Evidence-based screening strategies will improve identification of patients who are most likely to benefit from drug treatment to prevent fracture. In addition, careful consideration of when pharmacotherapy should be started and choice of medication and duration of treatment will maximize the benefits of fracture prevention while minimizing potential harms of long-term drug exposure.
科研通智能强力驱动
Strongly Powered by AbleSci AI